5
article
Milken Institute Statement on Newly Released FDA Guidance on Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Trials
The Milken Institute celebrates the publication of the second iteration of the Food and Drug Adminis
tration (FDA) draft guidance on Diversity Action Plans (DAP) to improve clinical trial diversity by enrolling underrepresented populations in the US.
+ Read More
article
Future of Aging Newsletter: Spring/Summer 2024
In This Edition
Global Conference Highlights
Project Spotlight
New Issue Brief
Thought Leadership
article
Milken Institute Announces Tech Hub Partners Program to Link Business Leaders and Investors to Regional Tech Innovation Opportunities
July 23, 2024 (Washington, DC)—The Milken Institute announced today the development of a Tech Hub Pa
rtners program to strengthen the network of 31 Regional Innovation and Technology Hubs (Tech Hubs) across the US to link business leader
+ Read More
article
An Update from MI Health—July 2024
In This Issue:
article
Medicare Drug Price Negotiation Program Comment Letter
Meena Seshamani, M.D., Ph.D.
Deputy Administrator and Director of the Center for Medicare
Centers fo
r Medicare & Medicaid Services
US Department of Health and Human Services
Baltimore, Maryland 21244
Dear Dr. Seshamani,
+ Read More